Program Directors oversee the research activities in one or more parts of the Institute's research funding program, managing a portfolio of grants and contracts and coordinating program efforts in these specifically defined areas of neuroscience research. Please reach out to individual Program Directors for more information about specific opportunities.
Use the quick search below to find your program director based on your research keywords.
Program Director/Program Manager | Portfolios |
---|---|
Mariam M. Afzal B.A. | Portfolio: NINDS Stroke Network (NIH StrokeNet); StrokeNet Thrombectomy Endovascular Platform (STEP); Clinical trials and epidemiology studies in treatment, recovery, and prevention of ischemic and hemorrhagic stroke; Data and Safety Monitoring Boards. |
Ramachandran Arudchandran Ph.D. | HEAL Biomarker Program |
Taryn Aubrecht Ph.D. | Portfolio: Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) |
Hibah O. Awwad Ph.D. | Basic and translational studies that relate to traumatic brain injury (TBI); cognitive/emotional domains affected by TBI; TBI-related dementia including Chronic Traumatic Encephalopathy (CTE), human subject research studies on pediatric TBI as well as TBI-related global health Additional keywords: Brain trauma, damage, and cortical impact; concussion; repetitive head injury; pre-clinical (animal models); diffuse axonal injury |
Debra Babcock M.D., Ph.D. | Basic and translational aspects of behavior and cognitive neuroscience; CNS plasticity; Lewy Body Dementia; neuroimaging development (disease-agnostic) |
Julia Bachman Ph.D. | HEAL Initiative Early Translational Efforts; HEAL PRECISION Human Pain Network |
Linda Bambrick Ph.D. | Responses to spinal cord injury or peripheral nerve injury, including axonal regeneration; interventions to promote recovery and/or restore function |
Richard T. Benson M.D., Ph.D. | Portfolio: Global Health and Health Disparities |
Francesca Bosetti Ph.D., Pharm.D. | Ischemic stroke, Cerebroprotection, Ischemic stroke animal models, primary and secondary stroke injury, post-stroke cognitive impairment, Ischemic stroke genetics. Additional keywords: Ischemic brain injury, white matter injury, Ischemic preconditioning and postconditioning, cerebrovascular protection, plasticity and repair after ischemic stroke; stroke comorbidities |
Chris Boshoff Ph.D. | Cooperative Research to enable and Advance Translational Enterprises (CREATE), Preclinical Neurotherapeutic Biologics Development |
Jeremy Brown M.D. | Portfolio: All aspects of emergency care research. NIH SIREN emergency care research network and clinical studies in adult and pediatric emergency neurology. Shared Interests: Traumatic brain injury, acute interventions for epilepsy, migraine and stroke. Exploratory and Efficacy clinical trials. |
Emily Caporello Ph.D. | Small Business funding (SBIR/STTR) for neurological disorders and pain; product development; translational and clinical research; neurotechnology |
Daofen Chen Ph.D. | Motor control and learning; device-based or behavioral interventions for movement disorders, stroke, and cerebral palsy; neural rehabilitation |
Sophie (Hyun Joo) Cho M.D. | Portfolio: Network for Excellence in Neuroscience Clinical Trials (NeuroNext). Clinical trials and studies in movement disorders, including Parkinson disease, dystonia, tremor, myoclonus, tic disorders. Clinical applications of neuromodulation, including deep brain stimulation, transcranial magnetic stimulation, and other non-invasive brain stimulation. Clinical applications of therapeutic neurotoxins. |
Ben Churn Ph.D. | Acquired epilepsies (with focus on circuit mechanisms, seizure initiation, seizure detection, seizure prediction); comorbidities and co-occurring conditions such as aging: cognitive impairments, intellectual disability (ID), post-traumatic epilepsy, stroke-induced seizures, seizures in aging and development; Refractory seizures and Status Epilepticus; basic research on synaptic transmission and plasticity, dendritic remodeling. Additional Keywords: Learning and memory; glutamatergic and GABAergic signaling |
Devon Crawford Ph.D. | Education and other projects related to improving research quality Additional keywords: rigor, transparency, reproducibility, replicability, research quality, research methodology, education, culture change, rigor icons, rigor champions |
Adi Cymerblit Sabba Ph.D. | Portfolio: NIH NeuroBioBank (human brain tissue banking) |
Charles Cywin Ph.D. | Portfolio: Blueprint Neurotherapeutics Network (BPN) Program and HEAL Optimization of Non-addictive Therapies [Small Molecules and Biologics] to Treat Pain |
William P. Daley Ph.D. | HIV-associated neurological disorders, infectious diseases of the nervous system, neurovirology, and Creutzfeldt-Jacob Disease and other transmissible spongiform encephalopathies HIV-associated neurological disorders, infectious diseases of the nervous system, neurovirology, and Creutzfeldt-Jacob Disease and other transmissible spongiform encephalopathies Additional Keywords: Neuroinfectious diseases; viral (HIV, HSV, ZIKV, SARS-CoV-2), bacterial, parasitic, and fungal CNS infection; prion-related disorders; Transmissible Spongiform Encephalopathy (TSE); Chronic Wasting Disease (CWD); Bovine Spongiform Encephalopathy (BSE); NeuroAIDS |
Karen David Ph.D. | BRAIN Integrated Approaches/Circuits Research Project Grants (R34, R01) and Team-research BRAIN Circuit Programs (U01,U19 ); NINDS Collaborative Opportunities for Multidisciplinary, Bold, and Innovative Neuroscience (COMBINE) (RM1); team science; non-traditional experimental systems Additional keywords: Integrative function of brain circuits; basic systems neuroscience; team science; non-traditional experimental systems |
Neel Dhruv Ph.D. | Portfolio: NINDS-wide mechanistic, translational and clinical studies that relate to the neural exposome. |
Argenia Doss Ph.D. | Portfolio: Trans-NIH Undiagnosed Diseases Network (UDN) |
Carlos Faraco Ph.D. | Portfolio: NIH StrokeNetwork (NIH StrokeNet); NIH Early Phase Pain Investigation Clinical Network (EPPIC-Net); Structural and functional magnetic resonance imaging (MRI) modalities; Atherosclerotic and idiopathic intracranial cerebrovascular disease; Alzheimer’s disease and Alzheimer’s disease-related dementias (AD/ADRDs); Postmortem imaging and neuropathology; Data and Safety Monitoring Boards (DSMBs) |
Nicole M. Farhat R.N., M.S., C.R.N.P. | Portfolio: Pediatric clinical trials and epidemiology studies, pediatric rare diseases |
Jessica C Forbes CCC-SLP; Ph.D | |
Jane Fountain Ph.D. | Primary brain tumor (pediatric and young adult) |
Megan Frankowski Ph.D. | Portfolio: Neurotechnology development and translation of stimulation & recording medical devices for neurodegenerative disorders (e.g., movement disorders, memory disorders) and neuropsychiatric disorders within these programs: BRAIN (Neural Recording and Modulation), BRAIN (Therapeutic Human Neuroscience), NINDS (Translational Neural Devices), Blueprint MedTech Keywords: Deep Brain Stimulation, Neuromodulation, Neuroimaging |
Lauren G. Friedman Ph.D. | Portfolio: Blueprint Neurotherapeutics Network for Biologics (BPN Biologics) Program |
Hermon R. Gebrehiwet DrPH , CCRP | Portfolio: Research Opportunities in Humans; BRAIN Initiative |
Annette Gilchrist Ph.D. | Portfolio: Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) applications |
Thomas N. Greenwell PhD | Basic, preclinical, and clinical research in pain; peripheral and central mechanisms, pathways, circuits and processing of pain |
Brooks Gross Ph.D. | Portfolio: Neurotechnology development and translation with an emphasis on epilepsy, neurotraumatic injuries (e.g., spinal cord injury, stroke, traumatic brain injury), neurodegenerative diseases (e.g., ALS, MS), cognition, sleep, and neurorehabilitation within these programs: NINDS (Translational Neural Devices), Blueprint MedTech, BRAIN (Neural Recording and Modulation), BRAIN (Therapeutic Human Neuroscience), SPARC (HORNET) Keywords: Neuromodulation, Neuroimaging, Neural Interfaces, Invasive and Non-invasive Therapeutic and Diagnostic Medical Devices |
Amelie Gubitz Ph.D. | Amyotrophic Lateral Sclerosis (ALS), Primary Lateral Sclerosis (PLS), Progressive Muscular Atrophy (PMA), ALS-Frontotemporal Degeneration (ALS-FTD) |
Kristina Hardy Ph.D. | Portfolio: Clinical trials and epidemiology studies related to neurodevelopment in the context of pediatric neurological disorders and disease impacting the central nervous system. In addition, human studies involving autistic individuals, particularly those examining sensory or sensory-motor functioning, pain, and sleep, or co-occurring with other medical conditions such as epilepsy. |
Adam Hartman M.D. | Portfolio: Clinical trials and epidemiology studies related to pediatric neurology, including epilepsy, neonatal/pediatric stroke, neuromuscular disorders, head trauma, cerebral palsy prevention, headache, hydrocephalus, neurological manifestations of genetic disorders (including mitochondrial diseases), neuroimmunological disorders/infections, and other areas. |
Janet He Ph.D. | CNS and homeostatic regulation of sleep and circadian rhythms; sleep in neurological disorders; neuroendocrine systems |
Rebecca Hommer M.D. | EPPIC-Net, HEAL Initiative, Vascular Contributions to Cognitive Impairment and Dementia (VCID), and Pediatric Research |
Nina Hsu Ph.D. | Portfolio: Neuroethics, Bioethics |
Eric Hudak Ph.D. | Portfolio: Neurotechnology development and translation for pain, migraine, neuralgia, and headache within these programs: NINDS (Translational Neural Devices), Blueprint MedTech, BRAIN (Therapeutic Human Neuroscience), HEAL (Translating Discoveries into Effective Devices to Treat Pain), SPARC (HORNET) Keywords: neuroprosthesis, neural engineering, neuromodulation, neural interfaces, open-source technology, electrochemistry, implantable materials, therapeutic and diagnostic medical devices |
Grace M. Hwang Ph.D. | BRAIN Initiative New Technologies (R01, RF1); BRAIN Initiative Optimization (U01) |
Smriti Iyengar Ph.D. | Portfolio: HEAL Initiative - Preclinical Screening Platform for Pain program, and Epilepsy Therapy Screening Program. |
Scott Janis Ph.D. | Portfolio: NINDS Stroke Network (NIH StrokeNet). Clinical trials and epidemiology studies in treatment, recovery, and prevention of ischemic and hemorrhagic stroke; trans-ischemic attacks; cryptogenic strokes, brain stem strokes, neuroimaging and stroke; stroke rehabilitation and pediatric stroke. |
David Jett Ph.D. | Portfolio: NINDS-wide mechanistic, translational and clinical studies relate to the neural exposome, neurotoxicology, chemical threats, and chemical safety
|
Kari Johnson Ph.D. | BRAIN CONNECTS Program; neurotechnology development; interdisciplinary neuroscience |
Brian Klein Ph.D. | Epilepsy Therapy Screening Program (ETSP), Preclinical Pharmacology, Animal Models. Preclinical Neurotherapeutic Development |
Svetlana Kotliarova Ph.D. | Primary brain tumor (adult, pediatric, and young adult) Additional keywords: Immunotherapy and immunosuppression; viral therapy; glioma stem cell biology; glioblastoma; medulloblastoma; diffuse intrinsic pontine gliomas (DIPG) |
Doe W. Kumsa PhD | Neural interface technologies that record, modulate, or stimulate neural activity; novel biomaterials for repair and neural interface devices; bioengineering applied to the nervous system (including development of hardware, software, and computational techniques) Additional keywords: Brain computer interfaces (BCI), neural and nerve interfaces; electrode development; microelectrode array; closed-loop deep brain stimulation (DBS); electrochemical sensors; brain implants; neural probe; nanotechnology; peripheral nerve injury |
Nicholas Langhals Ph.D. | Translational Neural Devices; Neural engineering with emphases in neuroprostheses, neuromodulation, brain-computer interface (BCI) devices, prosthetic control, and neural interface technology development |
Timothy LaVaute Ph.D. | Neurogenesis and progenitor cell biology in nervous system, stem cell applications for therapy development; therapeutic genome editing; tissue engineering; dendritic growth and plasticity |
Crystal A. Lee Ph.D. | Areas of Interest: Developmental neuroscience, neural epigenetics, Tuberous Sclerosis Complex, Fragile X Syndrome, Neurofibromatosis 1 and 2, Schwannomatosis Additional Keywords: motor neuron development, cerebellum development, higher order chromatin structures, miRNA, Noonan Syndrome |
Miriam Leenders Ph.D. | Acquired epilepsies (with focus on epilepsies with immunological or infectious etiology); epilepsy prevention strategies, disease modifying interventions, and cell replacement therapies; comorbidities and co-occurring conditions: auto-immune, viral, psychiatric and hormonal; Lafora Disease; temporal lobe epilepsy; basic research on synapse formation; tripartite synapse; metabolism in synaptic formation Additional Keywords: Neurogenesis; neuroinflammation; Temporal Lobe Epilepsy (TLE); synaptic development; synaptogenesis; intracellular synaptic signaling related to synapse development and formation; synapse regulation by astrocyte/glia |
Dina M Lyon MS, RN | Portfolio: Neuromuscular diseases including ALS, Expanded Access, ALS Consortium, DSMBs |
Marguerite Matthews Ph.D. | |
Amber McCartney Ph.D. | Portfolio: Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) |
Linda McGavern Ph.D. | Alzheimer's disease (AD), Limbic-predominant Age-related TDP-43 Encephalopathy (LATE), and Multiple Etiology Dementia (MED) |
Carolina Mendoza-Puccini M.D. | Portfolio: Common Data Elements (CDE)/ Data Standards, Digital Health Technology, Real World Data, AD/ADRD, Clinical Trials Readiness Project, Data Archiving, Intramural Monitoring, NIH Data Management and Sharing Policy (including GDPR), Clinical Trials/ Human Subjects. |
Daniel Miller Ph.D. | Huntington's Disease; invertebrate NMJ development, structure, and function; NIH NeuroBioBank (human brain tissue banking) Additional Keywords: Human brain single cell omics |
D.P. Mohapatra Ph.D. | Translational mechanistic pain research; itch, peripheral somatosensation, and glia/neuroimmune biology (non-pain); HEAL Initiative |
Jill Morris Ph.D. | Technology development for gene-targeted therapies; hydrocephalus and normal pressure hydrocephalus, neural tube defects (spina bifida); various rare diseases including inborn errors of metabolism, lysosomal storage disorders, leukodystrophies, brain iron accumulation disorders (NBIA), copper metabolism disorders, congenital disorders of glycosylation, mitochondrial disorders, and peroxisomal disorders), pediatric genetic vasculopathies, Ataxia Telangiectasia and basic studies on ATM mutation related DNA damage and DNA repair.
|
Glen Nuckolls Ph.D. | Muscular dystrophies; spinal muscular atrophy and inherited peripheral neuropathies (e.g. Charcot-Marie-Tooth, giant axonal neuropathy, familial dysautonomia) and inflammatory or autoimmune peripheral neuropathies (e.g. myasthenia gravis, Guillain-Barre Syndrome, chronic inflammatory demyelinating polyneuropathy); diabetic- and chemotherapy induced-peripheral neuropathies |
Joan Ohayon RN, MSN, CRNP, MSCN | Portfolio: Portfolio: Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT): Early phase clinical trials and biomarker studies preparatory to phase III clinical trials in neurological disorders, Data and Safety Monitoring Boards |
Leslie C. Osborne Ph.D. | Sensory and multi-sensory systems, cortical and thalamic circuits, integrative function of brain circuits, sensorimotor integration, computational neuroscience, and Collaborative Research in Computational Neuroscience (CRCNS), Smart and Connected Health (SCH) |
Michael Oshinsky Ph.D. | Migraine and other headache disorders; trigeminal pain; HEAL Initiative |
Mary Ann Pelleymounter Ph.D. | Portfolio: Pain Therapeutics Development Program (PTDP)/HEAL Optimization of Non-Addictive Therapies [Small Molecules and Biologics] to Treat Pain |
Rebecca Price Ph.D. | Portfolio: NINDS Biorepository (BioSEND); NINDS Human Cell and Data Repository (NHCDR); NINDS Biospecimen Resource Access Committees (BRACs) |
Michele L. Pucak | BRAIN Initiative Neurotechnology Development Program Additional keywords: Neural stimulation/recording devices; neuroimaging; integrative function of brain circuits; basic systems neuroscience |
Srikanth Ranganathan Ph.D. | Spinocerebellar Ataxias (SCAs), Friedreich’s Ataxia (FRDA/FA), Spinal and Bulbar Muscular Atrophy (SBMA), Hereditary Spastic Paraplegias (HSPs); Cell death mechanisms relevant to neurodegenerative disorders and not due to ischemia per se; Basic Mechanisms of Neurodegeneration including Mitochondrial / ER / Calcium homeostasis, RNA biology and protein turnover; Neuromuscular Junction Biology (vertebrate) |
Yogendra Raol Ph.D. | Portfolio: Epilepsy Therapy Screening Program (ETSP), translational and basic science research studies that relate to seizures and epilepsy |
K. Paul Rezaizadeh Ph.D. | Career Development Awards (K02, K08, K22, K23), Institutional Training Grants (T32), and Support for Scientific Conferences (R13/U13). |
Matthew Warner Rice Ph.D. | Portfolio: Management of pre-clinical drug discovery programs to facilitate therapeutic development of non-addictive pain medications. Keywords: Management of pre-clinical drug discovery programs to facilitate therapeutic development of non-addictive pain medications. |
Robert Riddle Ph.D. | Early pattern formation; cortical, cerebellar, midbrain, and hindbrain development; chromatin structure and function in the nervous system; epigenetic mechanisms; development and use of animal model systems; Joubert and Dandy-Walker Syndrome; Chiari Malformations; Down Syndrome and diseases related to intellectual developmental disorders; Fragile X Tremor Ataxia (FXTAS) |
Rebecca Roof Ph.D. | Portfolio: Innovation Grants to Nurture Initial Translational Efforts (IGNITE). Early-stage therapy development to include assay development, therapeutic screening, early-stage therapeutic characterization, pre-clinical efficacy testing, and development of translationally relevant animal models for disease. |
Cheryse A. Sankar Ph.D. | Health Disparities in Neurological Disorders and Stroke |
Shireen A. Sarraf Ph.D. | Structural, biochemical, molecular, and cellular aspects of Parkinson's disease (PD) and Lewy body dementia (LBD) as it relates to alpha-synuclein structure, mitochondrial biology, and lysosomal function; role of environmental factors in the etiology of synucleinopathies; basic studies of protein quality control (mitochondrial and lysosomal dysfunction, protein aggregation, mitophagy, autophagy) in the pathogenesis of PD and LBD |
Lumy Sawaki-Adams M.D., Ph.D. | Portfolio: NeuroCOVID/NeuroPASC, RECOVER initiative, ALS Expanded Access and ALS Consortium. Safety and Risk Assessment (SARAC). |
Gretchen C. Scott B.S, B.S.N., R.N. | Portfolio: Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN): SIREN infrastructure and clinical trial operations, executive oversight board liaison, clinical trial accrual monitoring, human subjects protection, and data management & sharing. Clinical trials and studies in neurosurgical-related disorders and treatment, including subdural hematoma and subarachnoid hemorrhage. Data Safety and Monitoring Boards. |
Frank Shewmaker Ph.D. | Frontotemporal Dementia (FTD), Frontotemporal Lobar Degeneration (FTLD), Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD), Primary Progressive Aphasia (PPA) |
Beth-Anne Sieber Ph.D. | Synucleinopathies, including Parkinson’s disease (PD), multiple system atrophy, and Lewy body dementias; preclinical and clinical studies evaluating cellular and molecular neurodegeneration, genetic, and other risk factors Additional Keywords: Functional neurobiology of genetic risk factors; gut-brain axis; microbiome; neuroimmune; neuroinflammation; mood, cognitive dysfunction; LRRK2; synuclein transmission; deep brain stimulation |
Shardell M. Spriggs Ph.D. | Neural Exposome, Refractory Epilepsy, Chemical Threats, and Dual use Research of Concern (DURC) |
Sudha Srinivasan Ph.D, M.P.H. | |
Christine Swanson-Fischer Ph.D. | Parkinson’s Disease (PD), Lewy Body Dementias (LBD), and related synucleinopathies focusing on biomarker discovery and validation, omics-based approaches, clinical genetics, epidemiology, and natural history studies |
Elizabeth I. Sypek Ph.D. | Portfolio: HEAL Initiative; HEAL Training and Workforce programs; pain |
Edmund Talley Ph.D. | BRAIN Initiative Neurotechnology Development Program, BRAIN CONNECTS Program |
Carol Taylor-Burds Ph.D. | Portfolio: Clinical biomarker development and validation studies for translation and implementation into clinical trials for therapeutic development or patient care. Development and validation of “digital” biomarkers and clinical outcome assessments derived from digital health technologies for remote monitoring in clinical trials. |
Natalie Trzcinski Ph.D. | BRAIN Initiative Research Resource Grants for Technology Integration and Dissemination (U24) |
Amy Y. Tsou M.D., M.Sc. | Portfolio: Neuromuscular diseases including ALS, neuroethics |
William Tyler Ph.D. | General glial biology; oligodendrocyte and Schwann cell development, function and myelination; basic astrocyte biology; neuronal polarity and migration; axon guidance; neurotrophic factors & associated signaling mechanisms in normal neurodevelopment; transcriptional regulation & gene expression in neurons; mechanisms of RNA transport and local translation in axons or dendrites; Angelman Syndrome Additional keywords: astrocytes; neurite outgrowth; neural cell migration; neuron-glia interactions |
Lauren Ullrich Ph.D. | |
George Umanah Ph.D. | Molecular structure, function, and regulation of ion channels, transporters, and pumps; channelopathy; mitochondria and mTORopathy mediated epileptic spasms and structural epilepsies; identifying novel genes, biomarkers, Machine Learning & Artificial Intelligence tools, and early-stage therapeutic research (mechanism-of-action of compounds and ligands) for the epilepsies and other neuronal disorders. Additional Keywords: Epilepsy therapeutics; machine learning & artificial intelligence for Epilepsy, structural biology; protein biochemistry and protein-protein interactions |
Nsini Umoh Ph.D. | Preclinical and clinical studies that relate to traumatic brain injury (TBI); cognitive/emotional domains affected by TBI; TBI-related dementia including Chronic Traumatic Encephalopathy (CTE) Additional keywords: Brain trauma, damage, and cortical impact; concussion; repetitive head injury; clinical (human) and preclinical; diffuse axonal injury |
Ursula Utz Ph.D., MBA | Multiple sclerosis and related disorders (including animal models thereof), studies on CNS demyelination and repair |
Letitia Weigand Ph.D. | Portfolio: Fellowships (F), Career Development Awards (K), Institutional Training Programs (T32), Research Education Programs (R25), UE5 for Residents and Fellows, Child Neurology Research Career Development Program (K12), Neurosurgeon Research Career Development Program (K12), Emergency Medicine Research Career Development Program in the Neurological Sciences (K12), Research Enhancement Awards (R15), NIH Loan Repayment Program (LRP), Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients, Research Supplements to Promote Re-Entry and Re-Integration into Health-Related Research Careers, Administrative Supplements to Promote Research Continuity and Retention of NIH First Time Recipients of NIH Research Project Grant (R) Awards Additional Key Words: Training, Career Development, K Award, Fellowship, Loan Repayment Program, Research Education, Graduate Student, Postdoctoral Fellowship |
Vicky Whittemore Ph.D. | Genetic epilepsies (excluding sodium, calcium and potassium channelopathies) ; metabolic epilepsy; sudden unexpected death in epilepsy (SUDEP); clinical epilepsy research; myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS); fatigue; alternating hemiplegia of children; epilepsy data science and data sharing Additional Keywords: Epilepsy comorbidities and biomarkers; epilepsies and dementia/aging or pregnancy; CDKL5 Deficiency Disorder; Genetic epilepsies |
Sarah Woller Ph.D. | Portfolio: Preclinical Screening Platform for Pain, NIH HEAL Initiative |
Guangying Wu Ph.D. | Portfolio: Neurotechnology development and translation forbrain-computer interfaces (BCI), brain-machine Interfaces (BMI), sensory and motor prostheses, limb loss, and neuro-interventional technologies, within these programs: NINDS (Translational Neural Devices), Blueprint MedTech, BRAIN (Neural Recording and Modulation), BRAIN (Therapeutic Human Neuroscience). Keywords: Neuromodulation, Neuroimaging, Neural Interfaces, Therapeutic and Diagnostic Medical Devices, Deep Brain Stimulation, Neurodiagnostic, Neuroprosthesis, Neuroprostheses, Neuroprosthetics |
Xiling Yin M.D., Ph.D. | Portfolio: Vascular Contributions to Cognitive Impairment and Dementia (VCID), for example Vascular Cognitive Impairment (VCI), Vascular Dementia (VaD), Cerebral Amyloid Angiopathy (CAA), and CADASIL Additional keywords: Small cerebral vessel diseases (e.g. atherosclerosis, arteriolosclerosis); post-stroke VCID; multi-infarct dementia; TBI with vascular lesions that lead to dementia; heart failure related to cognitive decline; cardiovascular and cerebrovascular dysfunction; anti-beta-amyloid immunotherapy |